Streetbeat News

Products Services

SAVA

Cassava Sciences, Inc. (NASDAQ:SAVA) saw a significant stock price increase after announcing an extension of its open-label extension trials for its Alzheimer's treatment, simufilam. The extension aims to provide continuous treatment for patients and gather more long-term data. The company is also conducting two major Phase 3 studies, with results expected in 2024 and 2025.

Portfolio Pulse from Vaishali Prayag

July 31, 2024 | 9:01 pm

AVDL

Avadel Pharmaceuticals (NASDAQ: AVDL) has announced the dosing of the first patient in its Phase 3 REVITALYZ trial for LUMRYZ, an extended-release oral suspension aimed at treating idiopathic hypersomnia.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:00 pm

IMRX

Immuneering Corporation (NASDAQ:IMRX) has been granted FDA Fast Track designation for its lead program, IMM-1-104, as a first-line treatment for pancreatic ductal adenocarcinoma (PDAC). This follows a previous Fast Track designation for second-line treatment. The company expects initial data from its Phase 2a trial in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 8:59 pm

ENVX

Enovix shares surged after the company reported better-than-expected Q2 financial results and announced a non-binding MOU with a Global Automotive OEM to scale its cell architecture into the EV market.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 8:55 pm

NFG

National Fuel Gas (NFG) has issued preliminary fiscal 2025 earnings guidance of $5.75-$6.25 per share, compared to the $6.29 estimate. The company expects modest long-term production growth and reduced capital expenditures in its non-regulated segments, driven by higher natural gas prices. Regulated segments are projected to see revenue growth due to recent rate cases and continued investments in system modernization. Overall, NFG anticipates stable and predictable returns for shareholders.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 8:54 pm

COIN

Coinbase Global (NASDAQ:COIN) is set to report its Q2 earnings, with analysts expecting revenue of $1.4 billion and earnings per share of 93 cents. The company has beaten revenue estimates for six straight quarters and earnings estimates for five straight quarters. Analysts have mixed ratings on Coinbase, with price targets ranging from $181 to $345. Key items to watch include commentary on Bitcoin and Ethereum ETFs and the impact of subscription and services revenue.

Portfolio Pulse from Chris Katje

July 31, 2024 | 8:44 pm

MDXG

MiMedx Group has announced the commercial launch of HELIOGEN Fibrillar Collagen Matrix, a particulate xenograft product designed for complex surgical wounds. HELIOGEN contains Type I and Type III collagen and mimics native structural connective tissue.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 8:44 pm

ENVX

Enovix Corporation has signed a non-binding Memorandum of Understanding (MOU) with a global automotive OEM to scale its cell architecture for the electric vehicle (EV) market. The focus will be on cell design and performance validation at the cell, pack, and vehicle levels to enhance performance and customer experience.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 8:39 pm

ENVX

Enovix Corporation has signed a collaboration agreement with a Fortune 200 company to supply silicon batteries for a rapidly growing IoT product category with tens of millions of users worldwide.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 8:39 pm

CVLT

MSFT

Commvault has announced a new cloud solution with premium Microsoft 365 backup storage, enhancing cyber resilience and recovery for Microsoft 365 workloads. The solution offers unified control and single-pane-of-glass monitoring via Commvault Cloud and is available through the Microsoft Azure Marketplace.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 8:38 pm